Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Prescription pain medications and chronic headache in Denmark : implications for preventing medication overuse. / Westergaard, Maria Lurenda; Hansen, Ebba Holme; Glümer, Charlotte; Jensen, Rigmor Højland.

I: European Journal of Clinical Pharmacology, Bind 71, Nr. 7, 07.2015, s. 851-60.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Westergaard, ML, Hansen, EH, Glümer, C & Jensen, RH 2015, 'Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse', European Journal of Clinical Pharmacology, bind 71, nr. 7, s. 851-60. https://doi.org/10.1007/s00228-015-1858-3

APA

Westergaard, M. L., Hansen, E. H., Glümer, C., & Jensen, R. H. (2015). Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. European Journal of Clinical Pharmacology, 71(7), 851-60. https://doi.org/10.1007/s00228-015-1858-3

Vancouver

Westergaard ML, Hansen EH, Glümer C, Jensen RH. Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. European Journal of Clinical Pharmacology. 2015 jul.;71(7):851-60. https://doi.org/10.1007/s00228-015-1858-3

Author

Westergaard, Maria Lurenda ; Hansen, Ebba Holme ; Glümer, Charlotte ; Jensen, Rigmor Højland. / Prescription pain medications and chronic headache in Denmark : implications for preventing medication overuse. I: European Journal of Clinical Pharmacology. 2015 ; Bind 71, Nr. 7. s. 851-60.

Bibtex

@article{9fe2027111ca4c15844d53cb66ba116a,
title = "Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse",
abstract = "PURPOSE: The aim of the present paper is to study which prescription pain medications are most commonly dispensed to people with chronic headache (CH), particularly those with medication-overuse headache (MOH).METHODS: This cross-sectional study analysed prescription pain medications dispensed within 1 year to 68,518 respondents of a national health survey. Participants with headache ≥15 days per month for 3 months were classified as having CH. Those with CH and over-the-counter analgesic use ≥15 days per month or purchase of ≥20 or ≥30 defined daily doses (DDDs) of prescription pain medication per month (depending on the drug) were classified as having MOH. Associations between CH and other chronic pain conditions were analysed by logistic regression.RESULTS: Among those with CH (adjusted prevalence 3.3 %, CI 3.2-3.5 %), pain medications most commonly dispensed were paracetamol, tramadol, ibuprofen and codeine. CH was associated with osteoarthritis, back pain, and rheumatoid arthritis. Among those with MOH, 32.4 % were dispensed an opioid at least once within 1 year. Only 5.1 % of people with CH were dispensed triptans.CONCLUSIONS: High prevalence of opioid use among people with CH may be due to inappropriate headache treatment or development of MOH among those treated for other pain conditions. While there were cases of triptan overuse, triptans remain underutilized among those with CH, suggesting that migraine may be under-recognized and inappropriately treated, leading to overuse of other medications. Education of physicians on appropriate headache management is essential for MOH prevention. There is a need to increase universal awareness about MOH as an adverse effect of long-term analgesic use.",
author = "Westergaard, {Maria Lurenda} and Hansen, {Ebba Holme} and Charlotte Gl{\"u}mer and Jensen, {Rigmor H{\o}jland}",
year = "2015",
month = jul,
doi = "10.1007/s00228-015-1858-3",
language = "English",
volume = "71",
pages = "851--60",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - Prescription pain medications and chronic headache in Denmark

T2 - implications for preventing medication overuse

AU - Westergaard, Maria Lurenda

AU - Hansen, Ebba Holme

AU - Glümer, Charlotte

AU - Jensen, Rigmor Højland

PY - 2015/7

Y1 - 2015/7

N2 - PURPOSE: The aim of the present paper is to study which prescription pain medications are most commonly dispensed to people with chronic headache (CH), particularly those with medication-overuse headache (MOH).METHODS: This cross-sectional study analysed prescription pain medications dispensed within 1 year to 68,518 respondents of a national health survey. Participants with headache ≥15 days per month for 3 months were classified as having CH. Those with CH and over-the-counter analgesic use ≥15 days per month or purchase of ≥20 or ≥30 defined daily doses (DDDs) of prescription pain medication per month (depending on the drug) were classified as having MOH. Associations between CH and other chronic pain conditions were analysed by logistic regression.RESULTS: Among those with CH (adjusted prevalence 3.3 %, CI 3.2-3.5 %), pain medications most commonly dispensed were paracetamol, tramadol, ibuprofen and codeine. CH was associated with osteoarthritis, back pain, and rheumatoid arthritis. Among those with MOH, 32.4 % were dispensed an opioid at least once within 1 year. Only 5.1 % of people with CH were dispensed triptans.CONCLUSIONS: High prevalence of opioid use among people with CH may be due to inappropriate headache treatment or development of MOH among those treated for other pain conditions. While there were cases of triptan overuse, triptans remain underutilized among those with CH, suggesting that migraine may be under-recognized and inappropriately treated, leading to overuse of other medications. Education of physicians on appropriate headache management is essential for MOH prevention. There is a need to increase universal awareness about MOH as an adverse effect of long-term analgesic use.

AB - PURPOSE: The aim of the present paper is to study which prescription pain medications are most commonly dispensed to people with chronic headache (CH), particularly those with medication-overuse headache (MOH).METHODS: This cross-sectional study analysed prescription pain medications dispensed within 1 year to 68,518 respondents of a national health survey. Participants with headache ≥15 days per month for 3 months were classified as having CH. Those with CH and over-the-counter analgesic use ≥15 days per month or purchase of ≥20 or ≥30 defined daily doses (DDDs) of prescription pain medication per month (depending on the drug) were classified as having MOH. Associations between CH and other chronic pain conditions were analysed by logistic regression.RESULTS: Among those with CH (adjusted prevalence 3.3 %, CI 3.2-3.5 %), pain medications most commonly dispensed were paracetamol, tramadol, ibuprofen and codeine. CH was associated with osteoarthritis, back pain, and rheumatoid arthritis. Among those with MOH, 32.4 % were dispensed an opioid at least once within 1 year. Only 5.1 % of people with CH were dispensed triptans.CONCLUSIONS: High prevalence of opioid use among people with CH may be due to inappropriate headache treatment or development of MOH among those treated for other pain conditions. While there were cases of triptan overuse, triptans remain underutilized among those with CH, suggesting that migraine may be under-recognized and inappropriately treated, leading to overuse of other medications. Education of physicians on appropriate headache management is essential for MOH prevention. There is a need to increase universal awareness about MOH as an adverse effect of long-term analgesic use.

U2 - 10.1007/s00228-015-1858-3

DO - 10.1007/s00228-015-1858-3

M3 - Journal article

C2 - 25967539

VL - 71

SP - 851

EP - 860

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 7

ER -

ID: 140571975